The molecular targeted agent, cetuximab and bevacizumab, combined with chemotherapy, would be more promising therapeutic regimens in the treatment of advanced gastric caner.

• 而将西妥昔单抗和贝伐单抗等分子靶向药物与化疗合用，有望成为更具前景的治疗方案。